Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?
Journal of Cosmetic Dermatology · 2024-02 · 23 (2) · 406-408
DOI: 10.1111/jocd.16030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 02.11.2023. Verfasst von Zeinab Aryanian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Pemphigus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Dermatology, Babol University of Medical Sciences, Babol, Iran.
ORCID-Profile: Parvaneh Hatami
Zitieren
APA
Aryanian, Z., Balighi, K., Emadi, S. N., & Hatami, P. (2024). Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?. Journal of Cosmetic Dermatology, 23(2), 406-408. https://doi.org/10.1111/jocd.16030
Vancouver
Aryanian Z, Balighi K, Emadi SN, Hatami P. Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?. Journal of Cosmetic Dermatology. 2024;23(2):406-408. doi:10.1111/jocd.16030
BibTeX
@article{Aryanian2024,
author = {Aryanian, Zeinab and Balighi, Kamran and Emadi, Seyed Naser and Hatami, Parvaneh},
title = {Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
volume = {23},
number = {2},
pages = {406--408},
doi = {10.1111/jocd.16030}
}
EUVIMED